Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem gel and cardiovascular changes in hypertensive patients undergoing FICO surgery
IRCT20200516047457N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of diltiazem in hypertension (HTN), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Cardiovascular changes during FICO surgery. Started Jun 2020; status: completed.
02
Drugs
diltiazem
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20200516047457N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200516047457N1.